IL17A and obesity due to melanocortin 4 receptor deficiency: However, the conflicting results observed in the different reported clinical studies regarding the impact of obesity on IL-17 inhibitors retention rate preclude any specific recommendation for the use of IL-17 inhibitors in this group of patients.